97 related articles for article (PubMed ID: 3014927)
1. Experimental bluetongue virus infection of sheep; effect of vaccination: pathologic, immunofluorescent, and ultrastructural studies.
Mahrt CR; Osburn BI
Am J Vet Res; 1986 Jun; 47(6):1198-203. PubMed ID: 3014927
[TBL] [Abstract][Full Text] [Related]
2. Experimental bluetongue virus infection of sheep; effect of previous vaccination: clinical and immunologic studies.
Mahrt CR; Osburn BI
Am J Vet Res; 1986 Jun; 47(6):1191-7. PubMed ID: 3014926
[TBL] [Abstract][Full Text] [Related]
3. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep.
Hamers C; Rehbein S; Hudelet P; Blanchet M; Lapostolle B; Cariou C; Duboeuf M; Goutebroze S
Vaccine; 2009 May; 27(21):2789-93. PubMed ID: 19366576
[TBL] [Abstract][Full Text] [Related]
4. Vaccines against bluetongue in Europe.
Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep.
Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M
Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189
[TBL] [Abstract][Full Text] [Related]
6. Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge.
Wade-Evans AM; Romero CH; Mellor P; Takamatsu H; Anderson J; Thevasagayam J; Fleming MJ; Mertens PP; Black DN
Virology; 1996 Jun; 220(1):227-31. PubMed ID: 8659119
[TBL] [Abstract][Full Text] [Related]
7. Risk factors associated with the occurrence of undesired effects in sheep and goats after field vaccination with modified-live vaccine against bluetongue virus serotypes 2, 4 and 16.
Savini G; Cannas A; Casaccia C; Di Gialleonardo L; Leone A; Patta C; Nicolussi P
Vet Microbiol; 2010 Nov; 146(1-2):44-50. PubMed ID: 20537822
[TBL] [Abstract][Full Text] [Related]
8. Immunologic response of sheep to inactivated and virulent bluetongue virus.
Stott JL; Barber TL; Osburn BI
Am J Vet Res; 1985 May; 46(5):1043-9. PubMed ID: 2988376
[TBL] [Abstract][Full Text] [Related]
9. Bluetongue virus RNA detection by RT-qPCR in blood samples of sheep vaccinated with a commercially available inactivated BTV-8 vaccine.
Steinrigl A; Revilla-Fernández S; Eichinger M; Koefer J; Winter P
Vaccine; 2010 Aug; 28(34):5573-81. PubMed ID: 20600511
[TBL] [Abstract][Full Text] [Related]
10. Clinical and serological response of sheep to serial challenge with different bluetongue virus types.
Jeggo MH; Gumm ID; Taylor WP
Res Vet Sci; 1983 Mar; 34(2):205-11. PubMed ID: 6304836
[TBL] [Abstract][Full Text] [Related]
11. An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy.
Savini G; Ronchi GF; Leone A; Ciarelli A; Migliaccio P; Franchi P; Mercante MT; Pini A
Vet Microbiol; 2007 Sep; 124(1-2):140-6. PubMed ID: 17499459
[TBL] [Abstract][Full Text] [Related]
12. Experimentally induced bluetongue virus infection in white-tailed deer: ultrastructural findings.
Howerth EW; Tyler DE
Am J Vet Res; 1988 Nov; 49(11):1914-22. PubMed ID: 2854710
[TBL] [Abstract][Full Text] [Related]
13. Nature and duration of protective immunity to bluetongue virus infection.
Roy P
Dev Biol (Basel); 2003; 114():169-83. PubMed ID: 14677687
[TBL] [Abstract][Full Text] [Related]
14. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle.
Savini G; Hamers C; Conte A; Migliaccio P; Bonfini B; Teodori L; Di Ventura M; Hudelet P; Schumacher C; Caporale V
Vet Microbiol; 2009 Jan; 133(1-2):1-8. PubMed ID: 18617335
[TBL] [Abstract][Full Text] [Related]
15. Experimental reproduction of severe bluetongue in sheep.
MacLachlan NJ; Crafford JE; Vernau W; Gardner IA; Goddard A; Guthrie AJ; Venter EH
Vet Pathol; 2008 May; 45(3):310-5. PubMed ID: 18487487
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology and diagnosis of bluetongue with particular reference to Corsica.
Breard E; Hamblin C; Hammoumi S; Sailleau C; Dauphin G; Zientara S
Res Vet Sci; 2004 Aug; 77(1):1-8. PubMed ID: 15120946
[TBL] [Abstract][Full Text] [Related]
17. Experimental bluetongue infections in gnotobiotic lambs and kids.
Livingston CW; McConnell S; Cummings G; Gauer BB
Am J Vet Res; 1983 Jan; 44(1):129-31. PubMed ID: 6297338
[TBL] [Abstract][Full Text] [Related]
18. Serial inoculation of sheep with two bluetongue virus types.
Jeggo MH; Wardley RC; Brownlie J; Corteyn AH
Res Vet Sci; 1986 May; 40(3):386-92. PubMed ID: 3016851
[TBL] [Abstract][Full Text] [Related]
19. Comparative safety study of three inactivated BTV-8 vaccines in sheep and cattle under field conditions.
Gethmann J; Hüttner K; Heyne H; Probst C; Ziller M; Beer M; Hoffmann B; Mettenleiter TC; Conraths FJ
Vaccine; 2009 Jun; 27(31):4118-26. PubMed ID: 19410620
[TBL] [Abstract][Full Text] [Related]
20. A comparison of intradermal and intravenous inoculation of bluetongue virus serotype 23 in sheep for clinico-pathology, and viral and immune responses.
Umeshappa CS; Singh KP; Channappanavar R; Sharma K; Nanjundappa RH; Saxena M; Singh R; Sharma AK
Vet Immunol Immunopathol; 2011 Jun; 141(3-4):230-8. PubMed ID: 21511346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
